CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

Today's IPO for CRISPR Therapeutics AG (Nasdaq: CRSP) opened for trading at $15 after pricing its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share.

Citigroup, Piper Jaffray and Barclays are acting as joint book-running managers for the offering. Guggenheim Securities is acting as co-manager.

CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.

You May Also Be Interested In

• OpenAI revenue chief quits after less than a year
• Nexon Releases Earnings for Second Quarter 2026
• Robinhood's second fund for retail investors eyeing private markets starts trading